title: Redotex ingestions reported to Texas poison centers.
abstract: Although the multi-component weight loss supplement Redotex is banned in the United States, the supplement can be obtained in Mexico. The intent of this report was to describe the pattern of Redotex calls received by a statewide poison center system. Cases were all Redotex calls received by Texas poison centers during 2000-2008. The distribution of total calls and those involving ingestion of the supplement were determined for selected demographic and clinical factors. Of 34 total Redotex calls received, 55.9% came from the 14 Texas counties that border Mexico. Of the 22 reported Redotex ingestions, 77.3% of the patients were female and 45.5% 20 years or more. Of the 17 ingestions involving no co-ingestants, 52.9% were already at or en route to a health care facility, 41.2% were managed on site, and 5.9% was referred to a health care facility. The final medical outcome was no effect in 23.5% cases, minor effect in 5.9%, moderate effect in 11.8%, not followed but minimal clinical effects possible in 47.1%, and unable to follow but judged to be potentially toxic in 11.8%. Most Redotex calls to the Texas poison center system originated from counties bordering Mexico.
authors.affiliation: Epidemiology and Disease Surveillance Unit, Texas Department of State Health Services, 1100W 49th Street, Austin, TX 78756, USA. mathias.forrester@dshs.state.tx.us
authors.forename: Mathias B
authors.initials: MB
authors.lastname: Forrester
mesh_terms: D017677:Age Distribution; D019440:Anti-Obesity Agents / Q000506:poisoning*; D001285:Atropine / Q000506:poisoning*; D003975:Diazepam / Q000506:poisoning*; D019587:Dietary Supplements / Q000506:poisoning*; D004338:Drug Combinations; D004642:Emodin / Q000031:analogs & derivatives* / Q000506:poisoning; D005260:Female; D006801:Humans; D008297:Male; D010665:Phenylpropanolamine / Q000506:poisoning*; D011039:Poison Control Centers / Q000706:statistics & numerical data*; D011041:Poisoning / Q000453:epidemiology; D012189:Retrospective Studies; D012737:Sex Factors; D013781:Texas / Q000453:epidemiology; D014284:Triiodothyronine / Q000506:poisoning*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019440:Anti-Obesity Agents; D004338:Drug Combinations; C578252:redotex; D014284:Triiodothyronine; D010665:Phenylpropanolamine; D001285:Atropine; D004642:Emodin; D003975:Diazepam